[HTML][HTML] Eculizumab dosing in infants
M Kobrzynski, B Wile, SS Huang… - Indian Journal of …, 2018 - journals.lww.com
Eculizumab is the therapy of choice for patients with atypical hemolytic uremic syndrome
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
Eculizumab Dosing in Infants.
M Kobrzynski, B Wile, SS Huang… - Indian Journal of …, 2018 - europepmc.org
Eculizumab is the therapy of choice for patients with atypical hemolytic uremic syndrome
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
[PDF][PDF] Eculizumab Dosing in Infants
M Kobrzynski, B Wile, SS Huang, G Filler - researchgate.net
Eculizumab is the therapy of choice for patients with atypical hemolytic uremic syndrome
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
Eculizumab Dosing in Infants
M Kobrzynski, B Wile, SS Huang… - Indian journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
Eculizumab is the therapy of choice for patients with atypical hemolytic uremic syndrome
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
Eculizumab Dosing in Infants.
M Kobrzynski, B Wile, SS Huang… - Indian Journal of …, 2018 - search.ebscohost.com
Eculizumab is the therapy of choice for patients with atypical hemolytic uremic syndrome
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
Eculizumab dosing in infants
M Kobrzynski, B Wile, S Huang… - Indian Journal of …, 2018 - search.proquest.com
Eculizumab is the therapy of choice for patients with atypical hemolytic uremic syndrome
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
Eculizumab Dosing in Infants
M Kobrzynski, B Wile, SS Huang, G Filler - Indian Journal of Nephrology, 2018 - ir.lib.uwo.ca
Eculizumab is the therapy of choice for patients with atypical hemolytic uremic syndrome
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
[HTML][HTML] Eculizumab Dosing in Infants
M Kobrzynski, B Wile, SS Huang… - Indian Journal of …, 2018 - ncbi.nlm.nih.gov
Eculizumab is the therapy of choice for patients with atypical hemolytic uremic syndrome
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
Eculizumab dosing in infants
M Kobrzynski, B Wile, S Huang, G Filler - Indian Journal of Nephrology, 2018 - go.gale.com
Eculizumab is the therapy of choice for patients with atypical hemolytic uremic syndrome
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
Eculizumab Dosing in Infants.
M Kobrzynski, B Wile, SS Huang… - Indian Journal of …, 2018 - europepmc.org
Eculizumab is the therapy of choice for patients with atypical hemolytic uremic syndrome
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …
(aHUS). Dosing recommendations stem from two trials: one retrospective trial (19 children …